Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-15-005027
Filing Date
2015-09-18
Accepted
2015-09-18 16:05:19
Documents
2
Period of Report
2015-09-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 16906
2 EX-24 DOCUMENT attachment1.htm EX-24 3926
  Complete submission text file 0000899243-15-005027.txt   22300
Mailing Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Issuer) CIK: 0001338042 (see all company filings)

EIN.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE MAIN STREET, SUITE 800 CAMBRIDGE MA 02142
Business Address
Harshbarger Benjamin (Reporting) CIK: 0001653133 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34921 | Film No.: 151115509